Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Fortrea Holdings Inc.FTRE · Entity 4623 | Director · Chief Executive Officer | March 20, 2025 | March 21, 2025 |
| IQVIA HOLDINGS INC.Q · Entity 3058 | Director · Vice Chair, Pres R&D Solutions | September 30, 2016 | October 04, 2016 |
| LABCORP HOLDINGS INC.LH · Entity 1277 | Pres & CEO Clinical Business | January 09, 2023 | January 11, 2023 |
| MARTIN MARIETTA MATERIALS INCMLM · Entity 587 | Director | August 31, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Fortrea Holdings Inc.
Report date March 20, 2025 · Filed March 21, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 359,342 |
Reported balance
After 2025-03-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-03-20 · Grant · Acquired 67,731 · Balance 359,342 F1: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") Common Stock. F2: The RSUs vest in two substantially equal installments on September 20, 2025 and September 20, 2026. F3: This number reflects the aggregate number of RSUs held by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of Fortrea Holdings Inc. ("Fortrea") Common Stock.
F2: The RSUs vest in two substantially equal installments on September 20, 2025 and September 20, 2026.
F3: This number reflects the aggregate number of RSUs held by the reporting person.
IQVIA HOLDINGS INC.
Report date September 30, 2016 · Filed October 04, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 124,936 |
Reported balance
After 2016-09-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-09-30 · Grant · Acquired 86,356 · Balance 124,936 F1: Grant to the reporting person of restricted stock under the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan (f/k/a the Quintiles Transnational Holdings Inc. 2013 Stock Incentive Plan) (the "Plan"). The restricted stock will vest in three equal installments on June 30, 2017, September 30, 2017 and December 31, 2017. F2: This amount includes 86,356 shares of restricted stock granted on September 30, 2016. |
| Common StockSEC Table I · non-derivative | Direct | 142,936 |
Reported balance
After 2016-10-03 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2016-10-03 · Grant · Acquired 18,000 · Balance 142,936 F3: Issuance to the reporting person of restricted stock units ("RSUs") under the Plan upon the conversion, at the effective time of the merger between Quintiles Transnational Holdings Inc. and IMS Health Holdings, Inc. (the "Merger"), of performance units ("PUs") originally issued to the reporting person on March 4, 2015. The PUs converted into RSUs at 187% of target, and the resulting RSUs will vest in full on December 31, 2017, the end of the original performance period of the PUs that were converted. F4: This amount includes 86,356 shares of restricted stock granted on September 30, 2016 and 18,000 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 4, 2015. |
| Common StockSEC Table I · non-derivative | Direct | 185,460 |
Reported balance
After 2016-10-03 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2016-10-03 · Grant · Acquired 42,524 · Balance 185,460 F5: Issuance to the reporting person of RSUs under the Plan upon the conversion, at the effective time of the Merger, of PUs originally issued to the reporting person on March 3, 2016. The PUs converted into RSUs at 100% of target, and the resulting RSUs will vest in full on December 31, 2018, the end of the original performance period of the PUs that were converted. F6: This amount includes 86,356 shares of restricted stock granted on September 30, 2016, 18,000 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 4, 2015 and 42,524 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 3, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant to the reporting person of restricted stock under the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan (f/k/a the Quintiles Transnational Holdings Inc. 2013 Stock Incentive Plan) (the "Plan"). The restricted stock will vest in three equal installments on June 30, 2017, September 30, 2017 and December 31, 2017.
F2: This amount includes 86,356 shares of restricted stock granted on September 30, 2016.
F3: Issuance to the reporting person of restricted stock units ("RSUs") under the Plan upon the conversion, at the effective time of the merger between Quintiles Transnational Holdings Inc. and IMS Health Holdings, Inc. (the "Merger"), of performance units ("PUs") originally issued to the reporting person on March 4, 2015. The PUs converted into RSUs at 187% of target, and the resulting RSUs will vest in full on December 31, 2017, the end of the original performance period of the PUs that were converted.
F4: This amount includes 86,356 shares of restricted stock granted on September 30, 2016 and 18,000 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 4, 2015.
F5: Issuance to the reporting person of RSUs under the Plan upon the conversion, at the effective time of the Merger, of PUs originally issued to the reporting person on March 3, 2016. The PUs converted into RSUs at 100% of target, and the resulting RSUs will vest in full on December 31, 2018, the end of the original performance period of the PUs that were converted.
F6: This amount includes 86,356 shares of restricted stock granted on September 30, 2016, 18,000 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 4, 2015 and 42,524 RSUs converted on October 3, 2016 from PUs originally issued to the reporting person on March 3, 2016.
LABCORP HOLDINGS INC.
Report date January 09, 2023 · Filed January 11, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 16,960 |
Reported balance
After 2023-01-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-01-09 · Grant · Acquired 16,960 · Balance 16,960 F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2: The Restricted Stock Units vest in three equal annual installments beginning on January 9, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vest in three equal annual installments beginning on January 9, 2024.
MARTIN MARIETTA MATERIALS INC
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,029 |
Reported balance
After 2026-08-31 transaction · row 1
1 source rowRow 1 · 2026-08-31 · Grant · Acquired 66 · Balance 5,029 F1: Common stock units were accrued under the Martin Marietta Materials, Inc. Common Stock Purchase Plan for Directors (the "Plan") and are to be settled in stock in a lump sum or in installments not to exceed 10 years commencing on (i) the date the reporting person ceases to be a Non-Employee Director, (ii) the date that is one month and one year following the date the reporting person ceases to be a Non-Employee Director, or (iii) the date elected by the Non-Employee Director that is later than the third anniversary of the date the fees are earned, in accordance with the reporting person's election under the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Common stock units were accrued under the Martin Marietta Materials, Inc. Common Stock Purchase Plan for Directors (the "Plan") and are to be settled in stock in a lump sum or in installments not to exceed 10 years commencing on (i) the date the reporting person ceases to be a Non-Employee Director, (ii) the date that is one month and one year following the date the reporting person ceases to be a Non-Employee Director, or (iii) the date elected by the Non-Employee Director that is later than the third anniversary of the date the fees are earned, in accordance with the reporting person's election under the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2016 Filed Oct 4, 2016 20:42 UTC | IQVIA HOLDINGS INC. Q · Entity 3058 | GrantCommon Stock | 86,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-144322 · doc4.xml · nonDerivative · entry 1 Pike Thomas · CIK 0001471570 · Director · Vice Chair, Pres R&D Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,936 F1 · security: Grant to the reporting person of restricted stock under the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan (f/k/a the Quintiles Transnational Holdings Inc. 2013 Stock Incentive Plan) (the "Plan"). The restricted stock will vest in three equal installments on June 30, 2017, September 30, 2017 and December 31, 2017. F2 · balance_after: This amount includes 86,356 shares of restricted stock granted on September 30, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.